Indefinite Delivery Contract SPE2DX18D1057

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.00, was awarded on November 16, 2017 and has an ultimate completion date of December 24, 2025. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, infectious disease prevention, and general medical care. The DLA, which oversees military healthcare programs, is the primary contracting agency for this IDC. No set-asides were used, indicating open competition. This single-award IDC serves as a primary vehicle for the DLA to efficiently procure essential pharmaceutical and medical commodities to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

In addition to the DLA IDC, Amerisourcebergen Drug Corp holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to serve as a critical supplier of pharmaceutical and medical supplies to multiple government agencies on a large scale, leveraging its extensive distribution capabilities and expertise in the healthcare sector.